Essex Bio-Technology Limited (1061.HK)
HKD 2.76
(0.37%)
HKD 2.76
(0.37%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -219.22 Million HKD | -307.85% |
| 2022 | -53.75 Million HKD | 49.36% |
| 2021 | -106.15 Million HKD | -186.83% |
| 2020 | -37 Million HKD | 64.43% |
| 2019 | -104.04 Million HKD | 14.53% |
| 2018 | -121.73 Million HKD | -47.29% |
| 2017 | -82.64 Million HKD | -2148.7% |
| 2016 | 4.03 Million HKD | 129.63% |
| 2015 | -13.61 Million HKD | -19.16% |
| 2014 | -11.42 Million HKD | -203.95% |
| 2013 | -3.75 Million HKD | -126.87% |
| 2012 | 13.98 Million HKD | 138.0% |
| 2011 | -36.81 Million HKD | 53.35% |
| 2010 | -78.9 Million HKD | -16.48% |
| 2009 | -67.74 Million HKD | -285.35% |
| 2008 | -17.57 Million HKD | -85.41% |
| 2007 | -9.48 Million HKD | 47.68% |
| 2006 | -18.12 Million HKD | 40.59% |
| 2005 | -30.49 Million HKD | -30.96% |
| 2004 | -23.28 Million HKD | -124.94% |
| 2003 | -10.35 Million HKD | 13.44% |
| 2002 | -11.95 Million HKD | 64.19% |
| 2001 | -33.4 Million HKD | -592.07% |
| 2000 | 6.78 Million HKD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -291.87 Million HKD | 0.0% |
| 2023 FY | -219.22 Million HKD | -307.85% |
| 2023 Q2 | -59.63 Million HKD | 0.0% |
| 2023 Q4 | -219.22 Million HKD | 0.0% |
| 2022 Q2 | -128.61 Million HKD | 0.0% |
| 2022 FY | -53.75 Million HKD | 49.36% |
| 2022 Q4 | -53.75 Million HKD | 0.0% |
| 2021 Q2 | -95.65 Million HKD | 0.0% |
| 2021 Q4 | -106.15 Million HKD | 0.0% |
| 2021 FY | -106.15 Million HKD | -186.83% |
| 2020 Q2 | -29.02 Million HKD | 0.0% |
| 2020 FY | -37 Million HKD | 64.43% |
| 2020 Q4 | -37 Million HKD | 0.0% |
| 2019 Q4 | -104.04 Million HKD | 0.0% |
| 2019 Q2 | -91.89 Million HKD | 0.0% |
| 2019 FY | -104.04 Million HKD | 14.53% |
| 2018 Q2 | -121.77 Million HKD | 0.0% |
| 2018 Q4 | -121.73 Million HKD | 0.0% |
| 2018 FY | -121.73 Million HKD | -47.29% |
| 2017 FY | -82.64 Million HKD | -2148.7% |
| 2017 Q2 | -3.88 Million HKD | 0.0% |
| 2017 Q4 | -82.64 Million HKD | 0.0% |
| 2016 Q4 | 4.03 Million HKD | 0.0% |
| 2016 Q2 | 77.64 Million HKD | 0.0% |
| 2016 FY | 4.03 Million HKD | 129.63% |
| 2015 Q4 | -13.61 Million HKD | 0.0% |
| 2015 Q2 | -42.47 Million HKD | 0.0% |
| 2015 FY | -13.61 Million HKD | -19.16% |
| 2014 Q2 | 6.34 Million HKD | 0.0% |
| 2014 Q4 | -11.42 Million HKD | 0.0% |
| 2014 FY | -11.42 Million HKD | -203.95% |
| 2013 Q4 | -3.75 Million HKD | 0.0% |
| 2013 FY | -3.75 Million HKD | -126.87% |
| 2013 Q2 | 12.5 Million HKD | 0.0% |
| 2012 Q4 | 13.98 Million HKD | 0.0% |
| 2012 FY | 13.98 Million HKD | 138.0% |
| 2012 Q2 | -15.39 Million HKD | 0.0% |
| 2011 FY | -36.81 Million HKD | 53.35% |
| 2011 Q4 | -36.81 Million HKD | 0.0% |
| 2011 Q2 | -66.05 Million HKD | 0.0% |
| 2010 Q2 | -68.41 Million HKD | 0.0% |
| 2010 FY | -78.9 Million HKD | -16.48% |
| 2009 FY | -67.74 Million HKD | -285.35% |
| 2008 FY | -17.57 Million HKD | -85.41% |
| 2007 FY | -9.48 Million HKD | 47.68% |
| 2006 FY | -18.12 Million HKD | 40.59% |
| 2005 FY | -30.49 Million HKD | -30.96% |
| 2004 FY | -23.28 Million HKD | -124.94% |
| 2003 FY | -10.35 Million HKD | 13.44% |
| 2002 FY | -11.95 Million HKD | 64.19% |
| 2001 FY | -33.4 Million HKD | -592.07% |
| 2000 FY | 6.78 Million HKD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Pak Fah Yeow International Limited | -258.7 Million HKD | 15.258% |
| Grand Pharmaceutical Group Limited | 2.03 Billion HKD | 110.79% |
| Extrawell Pharmaceutical Holdings Limited | 5.94 Million HKD | 3788.241% |
| Wai Yuen Tong Medicine Holdings Limited | 301.53 Million HKD | 172.704% |
| Qianhai Health Holdings Limited | -19.03 Million HKD | -1051.534% |
| Lee's Pharmaceutical Holdings Limited | 30.94 Million HKD | 808.379% |
| Tongfang Kontafarma Holdings Limited | 256.16 Million HKD | 185.582% |
| PuraPharm Corporation Limited | 377.54 Million HKD | 158.066% |
| SSY Group Limited | 1.71 Billion HKD | 112.794% |
| JBM (Healthcare) Limited | -7.39 Million HKD | -2862.955% |
| Jacobson Pharma Corporation Limited | 337.44 Million HKD | 164.968% |
| China Resources Pharmaceutical Group Limited | 50.97 Billion HKD | 100.43% |